包装: | 1mg |
规格: | 98% |
市场价: | 4815元 |
分子量: | 448.4 |
Background:
Raltegravir-d4is intended for use as an internal standard for the quantification of raltegravir by GC- or LC-MS. Raltegravir is an orally bioavailable inhibitor of HIV-1 integrase (IC50= 15 nM in a strand transfer assay).1It inhibits the spread of HIV-1IIIb infection in MT-4 cell culture with 95% cell culture inhibitory concentration (CIC95) values of 19 and 31 nM in medium containing 10% heat-inactivated fetal bovine serum (FBS) or 50% normal human serum, respectively. Formulations containing raltegravir have been used in combination therapy in the treatment of HIV-1 infection.
1.Summa, V., Petrocchi, A., Bonelli, F., et al.Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infectionJ. Med Chem.1(18)5843-5855(2008)
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024 |